featured
Semaglutide in Patients With Overweight or Obesity and Chronic Kidney Disease Without Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
Nat. Med. 2024 Oct 25;[EPub Ahead of Print], EM Apperloo, JL Gorriz, MJ Soler, S Cigarrán Guldris, JM Cruzado, MJ Puchades, M López-Martínez, F Waanders, GD Laverman, A van der Aart-van der Beek, K Hoogenberg, AP van Beek, J Verhave, SB Ahmed, RE Schmieder, C Wanner, DZI Cherney, N Jongs, HJL HeerspinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.